← Back
$ANTX All transactions

AN2 Therapeutics, Inc.

A

$ Value

$0

Shares

19,111

Price

$0

Filed

May 23

Insider

Name

Marks Gilbert Lynn

Title

CIK

0001916940

Roles

Director

Transaction Details

Transaction Date

2025-05-22

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

19,111

Footnotes

The option shares shall vest on March 31, 2026, subject to the Reporting Person providing continuous service through such date.

Filing Info

Accession No.

0000950170-25-077036

Form Type

4

Issuer CIK

0001880438

Marks Gilbert Lynn's History

Date Ticker Type Value
2026-04-10 ANTX A $0
2026-03-19 ANTX A
2026-03-19 ANTX D
2026-03-19 ANTX A
2026-03-19 ANTX D
2026-03-19 ANTX A
2026-03-19 ANTX D
2026-02-20 ANTX A $0
2026-01-12 ANTX A $0
2025-10-10 ANTX A $0

Other Insiders at ANTX (90d)

Insider Bought Sold Last
Zakrzewski Joseph S 2026-03-19
Spigelman Melvin K 2026-03-19
Wong Stephanie 2026-03-19
Chanda Sanjay
Chief Development Officer
2026-03-19
FitzPatrick Margaret M 2026-03-19
Easom Eric
Chief Executive Officer
2026-03-19
Day Lucy
Chief Financial Officer
2026-03-19
Aziz Kabeer 2026-04-10
Readnour Robin Shane 2026-03-19
Martin Patricia A. 2026-04-10
Marks Gilbert Lynn 2026-04-10
Eizen Joshua M
See Remarks
2026-03-19
Williams Sarah Joanne
Principal Accounting Officer
$347 2026-03-03